Briefly noted: B Barberio et al. Gastroenterol 2021; 161: 186-1877. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Key findings: Overall, pooled prevalence of PSC in IBD was 2.16%; the pooled prevalence was significantly higher in UC versus CD (OR 1.69)

Related blog posts:

• Aspen Webinar 2021 Part 5 -Autoimmune Liver Disease & PSC This lecture highlights studies show lack of efficacy with vancomycin, ursodeoxycholic acid and vedolizumab. Also, there is potential utility of MMP-7 for distinguishing between PSC and AIH
• Changes in Latitudes and Changes in Autoimmune Liver Disease
• Active Colitis More Likely in Children with PSC-IBD
• Big Study of PSC in Children
• PSC -Natural History Study (pediatric)
• Should We Care About Subclinical Primary Sclerosing Cholangitis with Inflammatory Bowel Disease?
• Primary Sclerosing Cholangitis (PSC) –Natural History Study